Zhejiang Govinda Biomedical Technology Co., Ltd. was registered and established in February 2020, located in Ningbo National High-tech Industry Development Zone, Zhejiang Province. The company covers an area of more than 2,000 square meters, with a registered capital of 10 million yuan and a total investment of more than 50 million yuan. In December 2021, it was selected into the seventh "High-tech Elite Plan" entrepreneurial team Category B in Ningbo National High-tech Zone (New Material Science and Technology City).

The company has established a pharmaceutical RESEARCH and development platform with modern instruments and equipment, committed to the development and research of pharmaceutical preparations, with insoluble pharmaceutical preparations, slow and controlled release pharmaceutical preparations, injection and lyophilized preparations, inhalation preparations and other technical research and development platforms. Can develop the research of drug release, gastric retention, osmotic pump, pulsed release agent, enteric preparation, multi-layer films, nanoparticle suspension injection, liposome preparations, inhalant (dry powder inhalation and aerosol), injection terminal sterilization, key technologies, such as terminal sterilization of a lyophilized dosage form development preparation products with high technical content. Through resource integration with upstream and downstream pharmaceutical companies, the company will establish long-term mutual trust and win-win partnership, create high-quality pharmaceutical research and development platform, and work together to create a beautiful, green health cause!